CSL Limited (1990 - )

Summary

The Commonwealth Serum Laboratories Commission became a public company in 1990, CSL Limited. CSL develops, manufactures and markets products such as pharmaceuticals and diagnostics, cell culture reagents, veterinary vaccines and human plasma products. CSL has manufacturing facilities both in Australia and overseas.

CSL Limited is an Australian public company specialising in the development, manufacture and marketing of biologically based health care products which benefit the community. [Source http://www.csl.com.au 2000-11-28)]

Details

Chronology

1990

Operational event - After convincing the Australian Government to consider CSL for privatisation, Dr Neville McCarthy steps down as Director. The Commission appoints 33 year-old Dr Brian McNamee as CEO.

1991

Operational event - CSL collaborates with Professor Ian Frazer to develop the world's first HPV vaccine. Merck & Co joins the partnership with a view to commercialising the vaccine globally.

1991

Operational event - CSL becomes incorporated as a Public Company with the aim to build a "great and independent Australian company". The Australian Government holds all shares in CSL. becomes incorporated as a Public Company with the aim to build a "great and independent Australian company". The Australian Government holds all shares in CSL.

1992

Operational event - CSL becomes a WHO Influenza Collaborating Centre, strengthening the organisation's role in the global influenza network.

1992

Business event - CSL undertakes its first acquisition, purchasing local animal sera supplier, Filtron, for A$2 million. The deal strengthens CSL's domestic cell culture business.

1993 - 2016

Publication - For a full list of events from "Celebrating 100, CSL" see the link below.

Related entries

Timeline

 1911 - 1916 Commonwealth Vaccine Depot
       1916 - 1961 Commonwealth Serum Laboratories
             1961 - 1990 Commonwealth Serum Laboratories Commission
                   1990 - CSL Limited

Published resources

Books

• CSL Board, Celebrating 100, CSL: Just getting started (Melbourne, Victoria: CSL Limited, 2016), 12 pp, https://www.eoas.info/bib-pdf/ASBS19098.pdf. Details

Journal Articles

• Gust, Ian, 'CSL, from blood stock to blue chip', Microbiology Australia, 41 (4) (2020), 183-6. https://doi.org/10.1071/MA20050. Details

Newspaper Articles

• Khadem, Nassim, 'Beautiful Blood: How CSL Grew From Humble Beginnings To Conquer The World', The Age (2018), 8-9. Details

Resources

• Wikidata, http://www.wikidata.org/entity/Q908265. Details
• VIAF - Virtual International Authority File, OCLC, https://viaf.org/viaf/136644939. Details
• Trove, National Library of Australia, 2009, https://nla.gov.au/nla.party-602054. Details

Resource Sections

• 'Primary description of agency CA 2576; Commonwealth Serum Laboratories/ (from 1990 Limited), Head Office', in RecordSearch, National Archives of Australia, 2000, https://RecordSearch.naa.gov.au/scripts/AutoSearch.asp?Number=CA%202576. Details
• 'Primary description of organisation CO 116; Commonwealth Serum Laboratories (CSL) Limited', in RecordSearch, National Archives of Australia, 2002, https://RecordSearch.naa.gov.au/scripts/AutoSearch.asp?Number=CO%20116. Details

See also

• Reed, Geoff A., 'Veterinarians in the development of an Australian pharmaceutical industry', Australian Veterinary History Record, 62 (2012), 9-36. Details